Cargando…

Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study

BACKGROUND: Direct-to-consumer telemedicine is an increasingly used modality to access primary care. Previous research on assessment using synchronous virtual visits showed mixed results regarding antibiotic prescription rates, and research on assessment using asynchronous chat-based eVisits is lack...

Descripción completa

Detalles Bibliográficos
Autores principales: Entezarjou, Artin, Calling, Susanna, Bhattacharyya, Tapomita, Milos Nymberg, Veronica, Vigren, Lina, Labaf, Ashkan, Jakobsson, Ulf, Midlöv, Patrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077790/
https://www.ncbi.nlm.nih.gov/pubmed/33720032
http://dx.doi.org/10.2196/25473
_version_ 1783684945176166400
author Entezarjou, Artin
Calling, Susanna
Bhattacharyya, Tapomita
Milos Nymberg, Veronica
Vigren, Lina
Labaf, Ashkan
Jakobsson, Ulf
Midlöv, Patrik
author_facet Entezarjou, Artin
Calling, Susanna
Bhattacharyya, Tapomita
Milos Nymberg, Veronica
Vigren, Lina
Labaf, Ashkan
Jakobsson, Ulf
Midlöv, Patrik
author_sort Entezarjou, Artin
collection PubMed
description BACKGROUND: Direct-to-consumer telemedicine is an increasingly used modality to access primary care. Previous research on assessment using synchronous virtual visits showed mixed results regarding antibiotic prescription rates, and research on assessment using asynchronous chat-based eVisits is lacking. OBJECTIVE: The goal of the research was to investigate if eVisit management of sore throat, other respiratory symptoms, or dysuria leads to higher rates of antibiotic prescription compared with usual management using physical office visits. METHODS: Data from 3847 eVisits and 759 office visits for sore throat, dysuria, or respiratory symptoms were acquired from a large private health care provider in Sweden. Data were analyzed to compare antibiotic prescription rates within 3 days, antibiotic type, and diagnoses made. For a subset of sore throat visits (n=160 eVisits, n=125 office visits), Centor criteria data were manually extracted and validated. RESULTS: Antibiotic prescription rates were lower following eVisits compared with office visits for sore throat (169/798, 21.2%, vs 124/312, 39.7%; P<.001) and respiratory symptoms (27/1724, 1.6%, vs 50/251, 19.9%; P<.001), while no significant differences were noted comparing eVisits to office visits for dysuria (1016/1325, 76.7%, vs 143/196, 73.0%; P=.25). Guideline-recommended antibiotics were prescribed similarly following sore throat eVisits and office visits (163/169, 96.4%, vs 117/124, 94.4%; P=.39). eVisits for respiratory symptoms and dysuria were more often prescribed guideline-recommended antibiotics (26/27, 96.3%, vs 37/50, 74.0%; P=.02 and 1009/1016, 99.3%, vs 135/143, 94.4%; P<.001, respectively). Odds ratios of antibiotic prescription following office visits compared with eVisits after adjusting for age and differences in set diagnoses were 2.94 (95% CI 1.99-4.33), 11.57 (95% CI 5.50-24.32), 1.01 (95% CI 0.66-1.53), for sore throat, respiratory symptoms, and dysuria, respectively. CONCLUSIONS: The use of asynchronous eVisits for the management of sore throat, dysuria, and respiratory symptoms is not associated with an inherent overprescription of antibiotics compared with office visits. TRIAL REGISTRATION: ClinicalTrials.gov NCT03474887; https://clinicaltrials.gov/ct2/show/NCT03474887
format Online
Article
Text
id pubmed-8077790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-80777902021-05-06 Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study Entezarjou, Artin Calling, Susanna Bhattacharyya, Tapomita Milos Nymberg, Veronica Vigren, Lina Labaf, Ashkan Jakobsson, Ulf Midlöv, Patrik JMIR Med Inform Original Paper BACKGROUND: Direct-to-consumer telemedicine is an increasingly used modality to access primary care. Previous research on assessment using synchronous virtual visits showed mixed results regarding antibiotic prescription rates, and research on assessment using asynchronous chat-based eVisits is lacking. OBJECTIVE: The goal of the research was to investigate if eVisit management of sore throat, other respiratory symptoms, or dysuria leads to higher rates of antibiotic prescription compared with usual management using physical office visits. METHODS: Data from 3847 eVisits and 759 office visits for sore throat, dysuria, or respiratory symptoms were acquired from a large private health care provider in Sweden. Data were analyzed to compare antibiotic prescription rates within 3 days, antibiotic type, and diagnoses made. For a subset of sore throat visits (n=160 eVisits, n=125 office visits), Centor criteria data were manually extracted and validated. RESULTS: Antibiotic prescription rates were lower following eVisits compared with office visits for sore throat (169/798, 21.2%, vs 124/312, 39.7%; P<.001) and respiratory symptoms (27/1724, 1.6%, vs 50/251, 19.9%; P<.001), while no significant differences were noted comparing eVisits to office visits for dysuria (1016/1325, 76.7%, vs 143/196, 73.0%; P=.25). Guideline-recommended antibiotics were prescribed similarly following sore throat eVisits and office visits (163/169, 96.4%, vs 117/124, 94.4%; P=.39). eVisits for respiratory symptoms and dysuria were more often prescribed guideline-recommended antibiotics (26/27, 96.3%, vs 37/50, 74.0%; P=.02 and 1009/1016, 99.3%, vs 135/143, 94.4%; P<.001, respectively). Odds ratios of antibiotic prescription following office visits compared with eVisits after adjusting for age and differences in set diagnoses were 2.94 (95% CI 1.99-4.33), 11.57 (95% CI 5.50-24.32), 1.01 (95% CI 0.66-1.53), for sore throat, respiratory symptoms, and dysuria, respectively. CONCLUSIONS: The use of asynchronous eVisits for the management of sore throat, dysuria, and respiratory symptoms is not associated with an inherent overprescription of antibiotics compared with office visits. TRIAL REGISTRATION: ClinicalTrials.gov NCT03474887; https://clinicaltrials.gov/ct2/show/NCT03474887 JMIR Publications 2021-03-15 /pmc/articles/PMC8077790/ /pubmed/33720032 http://dx.doi.org/10.2196/25473 Text en ©Artin Entezarjou, Susanna Calling, Tapomita Bhattacharyya, Veronica Milos Nymberg, Lina Vigren, Ashkan Labaf, Ulf Jakobsson, Patrik Midlöv. Originally published in JMIR Medical Informatics (http://medinform.jmir.org), 15.03.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on http://medinform.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Entezarjou, Artin
Calling, Susanna
Bhattacharyya, Tapomita
Milos Nymberg, Veronica
Vigren, Lina
Labaf, Ashkan
Jakobsson, Ulf
Midlöv, Patrik
Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study
title Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study
title_full Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study
title_fullStr Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study
title_full_unstemmed Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study
title_short Antibiotic Prescription Rates After eVisits Versus Office Visits in Primary Care: Observational Study
title_sort antibiotic prescription rates after evisits versus office visits in primary care: observational study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077790/
https://www.ncbi.nlm.nih.gov/pubmed/33720032
http://dx.doi.org/10.2196/25473
work_keys_str_mv AT entezarjouartin antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT callingsusanna antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT bhattacharyyatapomita antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT milosnymbergveronica antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT vigrenlina antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT labafashkan antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT jakobssonulf antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy
AT midlovpatrik antibioticprescriptionratesafterevisitsversusofficevisitsinprimarycareobservationalstudy